Abstract
Sacral neuromodulation (SNM) has emerged as a treatment option for refractory lower urinary tract and bowel dysfunction in children. SNM is typically reserved for a select population of children who have failed an extended period of behavioral modification, biofeedback, and pharmacologic therapy. The surgical techniques for SNM in children are analogous to those in adults and include both one- and two-stage procedures as well as a peripheral nerve evaluation with the InterStim® system (Medtronic, Minneapolis, MN). Most studies have observed not only an improvement in symptoms and quality of life in children undergoing SNM for non-neurogenic and neurogenic lower urinary tract dysfunction but also a much higher reoperative rate than in adults. Further high-quality research is necessary to corroborate the results of earlier studies and to better define the indications for SNM in children.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Zhang F, Zhao S, Shen B, Wang J, Nelson DE, Roppolo JR, et al. Neural pathways involved in sacral neuromodulation of reflex bladder activity in cats. Am J Physiol Ren Physiol. 2013;304:F710–7.
Hoebeke P, Bower W, Combs A, de Jong T, Yang S. Diagnostic evaluation of children with daytime incontinence. J Urol. 2010;183:699–703.
Austin PF, Bauer SB, Bower W, Chase J, Franco I, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the Standardization Committee of the International Children’s Continence Society. J Urol. 2014;191:1863–65.e13.
Rawashdeh YF, Austin P, Siggaard C, Bauer SB, Franco I, de Jong TP, et al. International Children’s Continence Society’s recommendations for therapeutic intervention in congenital neuropathic bladder and bowel dysfunction in children. Neurourol Urodyn. 2012;31:615–20.
Gamé X, Mouracade P, Chartier-Kastler E, Viehweger E, Moog R, Amarenco G, et al. Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. J Pediatr Urol. 2009;5:156–64.
Chase J, Austin P, Hoebeke P, McKenna P. The management of dysfunctional voiding in children: a report from the Standardisation Committee of the International Children’s Continence Society. J Urol. 2010;183:1296–302.
Hassouna T, Gleason JM, Lorenzo AJ. Botulinum toxin A’s expanding role in the management of pediatric lower urinary tract dysfunction. Curr Urol Rep. 2014;15:426.
De Gennaro M, Capitanucci ML, Mosiello G, Zaccara A. Current state of nerve stimulation technique for lower urinary tract dysfunction in children. J Urol. 2011;185:1571–7.
Guys JM, Haddad M, Planche D, Torre M, Louis-Borrione C, Breaud J. Sacral neuromodulation for neurogenic bladder dysfunction in children. J Urol. 2004;172:1673–6. This is only 1 of 2 prospective randomized controlled trials, investigating the use of SNM in children with neurogenic LUTD.
Humphreys MR, Vandersteen DR, Slezak JM, Hollatz P, Smith CA, Smith JE, et al. Preliminary results of sacral neuromodulation in 23 children. J Urol. 2006;176:2227–31.
Roth TJ, Vandersteen DR, Hollatz P, Inman BA, Reinberg YE. Sacral neuromodulation for the dysfunctional elimination syndrome: a single center experience with 20 children. J Urol. 2008;180:306–11.
Haddad M, Besson R, Aubert D, Ravasse P, Lemelle J, El Ghoneimi A, et al. Sacral neuromodulation in children with urinary and fecal incontinence: a multicenter, open label, randomized, crossover study. J Urol. 2010;184:696–701. This is only 1 of 2 prospective randomized controlled trials, investigating the use of SNM in children with neurogenic LUTD.
Groen LA, Hoebeke P, Loret N, Van Praet C, Van Laecke E, Ann R, et al. Sacral neuromodulation with an implantable pulse generator in children with lower urinary tract symptoms: 15-year experience. J Urol. 2012;188:1313–7.
Stephany HA, Juliano TM, Clayton DB, Tanaka ST, Thomas JC, Adams MC, et al. Prospective evaluation of sacral nerve modulation in children with validated questionnaires. J Urol. 2013;190:1516–22.
Dwyer ME, Vandersteen DR, Hollatz P, Reinberg YE. Sacral neuromodulation for the dysfunctional elimination syndrome: a 10-year single-center experience with 105 consecutive children. Urology. 2014;84:911–7. This is the largest series of children undergoing SNM due to LUTD.
Medtronic Sacral Neuromodulation System Information for Prescribers. Medtronic, Inc. 2012. http://professional.medtronic.com/pt/uro/snm/prod/index.htm. Accessed 31 Jan 2015.
McGee SM, Routh JC, Granberg CF, Roth TJ, Hollatz P, Vandersteen DR, et al. Sacral neuromodulation in children with dysfunctional elimination syndrome: description of incisionless first stage and second stage without fluoroscopy. Urology. 2009;73:641–4.
Fox JA, Reinberg YE. Incontinence. Pediatric sacral neuromodulation for refractory incontinence. Nat Rev Urol. 2010;7:482–3.
van Wunnik BP, Peeters B, Govaert B, Nieman FH, Benninga MA, Baeten CG. Sacral neuromodulation therapy: a promising treatment for adolescents with refractory functional constipation. Dis Colon Rectum. 2012;55:278–85.
Clark C, Ngo T, Comiter CV, Anderson R, Kennedy W. Sacral nerve stimulator revision due to somatic growth. J Urol. 2001;186:1576–80.
Compliance with Ethics Guidelines
Conflict of Interest
No authors have any conflicts of interest to disclose.
Human and Animals Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Neurogenic Bladder
Rights and permissions
About this article
Cite this article
Strine, A.C., Keenan, A.C., King, S. et al. Sacral Neuromodulation in Children. Curr Bladder Dysfunct Rep 10, 332–337 (2015). https://doi.org/10.1007/s11884-015-0322-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11884-015-0322-7